1 Department of Cardiology, Isala Hospital, The Netherlands.
2 Department of Cardiology, University Hospital Coventry, UK.
Eur Heart J Acute Cardiovasc Care. 2018 Mar;7(2):102-110. doi: 10.1177/2048872616687116. Epub 2017 Jan 13.
The first study of the FamouS Triage project investigates the feasibility of ruling out a myocardial infarction in pre-hospital chest pain patients without electrocardiographic ST-segment elevation by using the modified HEART score at the patient's home, incorporating only a single highly sensitive troponin T measurement.
A venous blood sample was drawn in the ambulance from 1127 consecutive chest pain patients for measurement of the pre-hospital highly sensitive troponin T levels, in order to establish a pre-hospital HEART score (i.e. the modified HEART score) and evaluate the possibility of triage at the patient's home. The primary endpoint was the occurrence of a major adverse cardiac event (MACE) i.e. acute myocardial infarction, percutaneous coronary intervention, coronary artery bypass grafting or death within 30 days after initial presentation.
Two hundred and six patients (18%) developed a MACE during 30 days of follow-up. Thirty-six per cent of the patients ( n=403) had a low modified HEART score (0-3 points) and none of them developed a MACE during follow-up. Forty-four per cent of the patients ( n=494) had an intermediate modified HEART score (4-6 points) and 18% of them developed a MACE. Twenty per cent of the patients ( n=230) had a high modified HEART score (7-10 points) of which 52% developed a MACE during follow-up.
It seems feasible to rule out a myocardial infarction at home in chest pain patients without ST-segment elevation by using the modified HEART score.
NTR4205. Dutch Trial Register [ http://www.trialregister.nl ]: trial number 4205.
FamouS Triage 项目的第一项研究旨在调查在院前胸痛患者中,通过在家中使用改良 HEART 评分(仅包含单次高敏肌钙蛋白 T 测量)来排除心电图 ST 段抬高型心肌梗死的可行性。
从 1127 例连续胸痛患者的救护车上抽取静脉血样,用于测量院前高敏肌钙蛋白 T 水平,以建立院前 HEART 评分(即改良 HEART 评分)并评估在患者家中分诊的可能性。主要终点是 30 天内发生主要不良心脏事件(MACE)即急性心肌梗死、经皮冠状动脉介入治疗、冠状动脉旁路移植术或死亡。
206 例患者(18%)在 30 天的随访中发生了 MACE。36%的患者(n=403)改良 HEART 评分低(0-3 分),且随访期间均未发生 MACE。44%的患者(n=494)改良 HEART 评分中等(4-6 分),18%发生了 MACE。20%的患者(n=230)改良 HEART 评分高(7-10 分),其中 52%在随访期间发生了 MACE。
似乎可以通过使用改良 HEART 评分在家中排除无 ST 段抬高的胸痛患者的心肌梗死。
NTR4205.荷兰试验注册中心[http://www.trialregister.nl]:试验编号 4205。